124 related articles for article (PubMed ID: 37924516)
21. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
Hamdan FH; Johnsen SA
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
23. Landscape of enhancer disruption and functional screen in melanoma cells.
Wang Z; Luo M; Liang Q; Zhao K; Hu Y; Wang W; Feng X; Hu B; Teng J; You T; Li R; Bao Z; Pan W; Yang T; Zhang C; Li T; Dong X; Yi X; Liu B; Zhao L; Li M; Chen K; Song W; Yang J; Li MJ
Genome Biol; 2023 Oct; 24(1):248. PubMed ID: 37904237
[TBL] [Abstract][Full Text] [Related]
24. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
25. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
[TBL] [Abstract][Full Text] [Related]
26. [KLF6 Super-enhancer Regulates Cell Proliferation by Recruiting GATA2 and SOX10 in Human Hepatoma Cells].
Ri KC; Ryong Ri M; Hun Kim K; Choe SI; Ri JH; Kim JH; Ri JH
Mol Biol (Mosk); 2022; 56(3):498-499. PubMed ID: 35621105
[TBL] [Abstract][Full Text] [Related]
27. Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma.
Fulciniti M; Lin CY; Samur MK; Lopez MA; Singh I; Lawlor MA; Szalat RE; Ott CJ; Avet-Loiseau H; Anderson KC; Young RA; Bradner JE; Munshi NC
Cell Rep; 2018 Dec; 25(13):3693-3705.e6. PubMed ID: 30590042
[TBL] [Abstract][Full Text] [Related]
28. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract][Full Text] [Related]
29. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
30. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.
Wang C; Zhang L; Ke L; Ding W; Jiang S; Li D; Narita Y; Hou I; Liang J; Li S; Xiao H; Gottwein E; Kaye KM; Teng M; Zhao B
Nat Commun; 2020 Dec; 11(1):6318. PubMed ID: 33298918
[TBL] [Abstract][Full Text] [Related]
31. Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation.
Mendelson K; Martin TC; Nguyen CB; Hsu M; Xu J; Lang C; Dummer R; Saenger Y; Messina JL; Sondak VK; Desman G; Hasson D; Bernstein E; Parsons RE; Celebi JT
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38319712
[TBL] [Abstract][Full Text] [Related]
32. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
33. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.
Di Benedetto C; Oh J; Choudhery Z; Shi W; Valdes G; Betancur P
BMC Cancer; 2022 Oct; 22(1):1056. PubMed ID: 36224576
[TBL] [Abstract][Full Text] [Related]
34. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
35. Dissecting super-enhancer heterogeneity: time to re-examine cancer subtypes?
Wu T; Huang H; Wang X
Trends Genet; 2022 Dec; 38(12):1199-1203. PubMed ID: 35803787
[TBL] [Abstract][Full Text] [Related]
36. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
37. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
Gen Y; Muramatsu T; Inoue J; Inazawa J
Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
[TBL] [Abstract][Full Text] [Related]
38. Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma.
Zhang L; Li H; Qiu Y; Liu Y; Liu X; Wang W
Bioengineered; 2021 Dec; 12(2):10073-10088. PubMed ID: 34709988
[TBL] [Abstract][Full Text] [Related]
39. Differentiated super-enhancers in lung cancer cells.
Li X; Lu C; Lu Q; Li C; Zhu J; Zhao T; Chen H; Jin H
Sci China Life Sci; 2019 Sep; 62(9):1218-1228. PubMed ID: 30635833
[TBL] [Abstract][Full Text] [Related]
40. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
